Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is ...

Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high mortality rate. Cisplatin-based chemotherapy has demonstrated prolonged survival of ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...

This trial is for people with non muscle invasive bladder cancer who are going to have treatment with BCG into the bladder for the first time. Read more about A trial looking at durvalumab and BCG for ...

This trial looked at different doses of radiotherapy for transitional cell bladder cancer. It was for people whose cancer had grown into the wall of the bladder. This is called muscle invasive bladder ...

Instead, transitional cell carcinoma starts in your renal pelvis, the top part of your ureter. Your ureter is the tube that ...

MCLA-145 is under clinical development by Merus and currently in Phase I for Bladder Cancer. According to GlobalData, Phase I drugs for Bladder Cancer have a 75% phase transition success rate (PTSR) ...

My story starts with a cancer I developed seven years ago. A cystoscopy revealed transitional cell cancer. The kidney, ureter and a little part of the bladder where the ureter enters the bladder were ...

Bemarituzumab is under clinical development by Amgen and currently in Phase III for Bladder Cancer. According to GlobalData, Phase III drugs for Bladder Cancer have a 47% phase transition success rate ...